OPRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. Despite solid Q3 growth, OPRA is still in a bearish technical structure (SMA200>SMA20>SMA5) and is trading below its key pivot (13.883) in pre-market (~13.4). With no proprietary buy signals today and no near-term news catalyst, the risk of chop/continued drift toward support is higher than the odds of an immediate upside breakout. I would wait; if already owned, hold rather than add here.
Trend/structure: Bearish (SMA_200 > SMA_20 > SMA_5), implying the path of least resistance remains down until price reclaims key levels. Momentum: MACD histogram slightly positive (0.00407) but contracting—suggests weak/fragile upside momentum rather than a strong reversal. RSI_6 ~41.65 is neutral-to-soft (not oversold enough to signal a high-conviction bounce). Levels: Pre-market ~13.4 sits below Pivot 13.883 (bearish positioning). Nearby support is S1 13.253 (failure there risks S2 12.863). Upside resistance is R1 14.513 then R2 14.903; a convincing buy setup would typically require reclaiming the pivot and holding above it.
Intellectia Proprietary Trading Signals
Fundamentals are improving: 2025/Q3 revenue +22.81% YoY and EPS +110% YoY.
Options sentiment is bullish-leaning (call-heavy positioning).
Upcoming earnings: QDEC 2025 earnings on 2026-02-27 (pre-market) could act as a catalyst if results/guide surprise positively.
Price trend remains bearish (moving averages stacked bearishly) and pre-market is below the pivot level.
Gross margin declined in 2025/Q3 (62.2%, down 11.04% YoY), which can weigh on multiple expansion.
No supportive news flow in the last week; lacking near-term catalysts increases the odds of continued consolidation or drift toward support.
High implied volatility increases the cost/risk of chasing upside via options and often coincides with sharp swings.
Latest quarter: 2025/Q3. Revenue: $152.114M, up 22.81% YoY (strong top-line growth). Net income: $18.618M, up 3.78% YoY (positive but slower than revenue). EPS: $0.21, up 110% YoY (strong per-share improvement). Gross margin: 62.2%, down 11.04% YoY (key negative—suggests profitability quality/efficiency weakened even as revenue grew).
No analyst rating/price target change data was provided, so a trend summary cannot be confirmed. Wall Street-style pros from the available data: accelerating revenue and sharply higher EPS. Cons: margin compression and a still-bearish technical trend, which often keeps analysts cautious on near-term upside.
